Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03484520
Title A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
University of Arkansas /ID# 200016 Little Rock Arkansas 72205 United States Details
David Geffen School of Medicin /ID# 200015 Los Angeles California 90095 United States Details
The University ofChicago /ID# 200017 Chicago Illinois 60637 United States Details
University of Maryland School of Medicine /ID# 204015 Baltimore Maryland 21201-1544 United States Details
Wake Forest Baptist Medical Center /ID# 200288 Winston-Salem North Carolina 27157-0001 United States Details
The Ohio State University /ID# 200668 Columbus Ohio 43210 United States Details
University of Texas MD Anderson Cancer Center /ID# 205215 Houston Texas 77030 United States Details
Gold coast University Hospital /ID# 202759 SouthPort Queensland 4215 Australia Details
Royal Hobart Hospital /ID# 202763 Hobart Tasmania 7000 Australia Details
Monash Medical Centre /ID# 202762 Melbourne Victoria 3168 Australia Details
Hospital Universitario Ramon y Cajal /ID# 201729 Madrid 28034 Spain Details
Hospital Universitario de Salamanca /ID# 201728 Salamanca 37711 Spain Details
Hospital Universitario y Politecnico La Fe /ID# 202318 Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field